Form D — Xenagos Bio, Inc.
0002134608-26-000001 · filed 2026-05-15
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $2,520,000
- Total sold
- $2,520,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Xenagos Bio, Inc.
- CIK
- 2134608
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 121 S. BROAD ST., 15TH FLOOR, #1015
PHILADELPHIA, PA 19107 - Phone
- (610) 716-3542
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Michael J. McElhaugh · Executive OfficerPhiladelphia, PA Find on LinkedIn ↗
-
Abel De La Rosa · DirectorPhiladelphia, PA Find on LinkedIn ↗
-
Patrick Higgins · DirectorPhiladelphia, PA Find on LinkedIn ↗
View original on SEC EDGAR.